This conflicts with what someone else posted a week or two ago, so let’s see if anyone can chime in here.
I did find this, which means if they were actually conducting human clinical trials, there are some things that have to be made public. A quick Google search also reveals that over 90% of IND filings are immediately publicly disclosed.
“The revised Common Rule (45 CFR 46.116(h)) requires that for any clinical trial conducted or supported by a Common Rule department or agency, one consent form used in enrolling participants be posted on a publicly available Federal website within a specific time frame. In an August 2018 announcement, ClinicalTrials.gov and Regulations.gov were identified as the publicly available federal websites that will satisfy the consent form posting requirement.”
Add to that the fact they are still trading as a public company and PINK current and have fiduciary responsibility to update shareholders. OTCmarkets does require most material events to be made public to shareholders at least by the yearly report.
SEC reporting would also require any material event to be published publicly within 4 business days. If they just recently filed an IND, how long can he privately sit on that info? Maybe this is one reason Charles has held off? We know for a fact he’s already been sitting on completed 2 year audits for an entire quarter now.
I think it’s next to impossible the more you look into clinical trials as well as requirements for publicly traded companies, (even OTC pink tier) that we would be currently conducting human clinical trials in secret. Next to no chance that is occurring and we don’t know about it.
